PCVX

NASD Vaxcyte, Inc.
Oct 6, 2026 · 7:15 AM ET LAST TRADE Market Closed

$71.53 ↓ -2.29 (-3.10%) Trading Down from the previous close of $73.82

YTD change
+55.03%
vs 20-day SMA
+21.24%
vs 200-day SMA
+29.37%

Price ranges

Previous day
$71.60 $90.75
open $86.74 close $73.82
-$12.92 (-14.90%)
Today
$0.00 $0.00
$71.53
Past week
$55.84 $90.75
from $58.27 now $71.53
+$13.26 (+22.76%)
Past month
$55.09 $90.75
from $61.16 now $71.53
+$10.37 (+16.96%)
This year
$43.95 $90.75
from $46.14 now $71.53
+$25.39 (+55.03%)

Price & Performance

+14.00 (+23.40%) / 6M

$43.15$54.13$65.11$76.09Apr 6Jul 7Oct 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 40.9% away from all-time highs of $121.06
  • PCVX is up 55% since the beginning of the year
  • PCVX is up 74% over the past 12 months
  • PCVX is up 17% over the past 1 month
  • 11% of all PCVX investors are betting against PCVX

PCVX reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +79.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.97
Earnings momentum +10.3% Quarterly EPS growth
Quarterly change +10.3%

Valuation

P/E ratio N/A
Enterprise value $9.3B
Beta 1.54

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$1.5B
Debt$115.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $10.6B

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $402.98 -0.01%
MRNA Moderna, Inc. $203.21 +6.95%
RVMD Revolution Medicines, Inc. $207.68 +0.50%
ROIV Roivant Sciences Ltd. $35.78 +0.17%
BNTX BioNTech SE Sponsored ADR $97.64 +0.76%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.